References
- Else M, Dearden C, Matutes E, Long-term follow up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733–740.
- Saven A, Burian C, Koziol JA, Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918–1926.
- Sigal, D, Sharpe R, Burian C, Saven A. Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood 2010;115:1893–1896.
- Saven A. Hairy cell leukemia. Williams Hematology. In: Lichtman MA, Kipps TJ, Kaushansky K, et al, editors. 7th ed. New York: McGraw-Hill; 2006. pp 1385–1393.
- Carson DA, Wasson DB, Kaye J, Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci USA 1980;77:6865–6869.
- Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340:952–956.
- Piro LD, Carrera CJ, Carson DA, Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117–1121.
- Goodman GR, Burian C, Koziol JA, Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891–896.
- Dearden CE, Matutes, E, Hilditch BL, Long-term follow-up of patients with hairy cell leukemia after treatment with pentostatin or cladribine. Br J Haematol 1999;106:515–519.
- Wheaton S, Tallman MS, Hakimian D, Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood 1996;87:1556–1560.
- Ellison DJ, Sharpe RW, Robbins BA, Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leuekmia. Blood 1994;84:4310–4315.
- Sigal D, Miller H, Schram E, Saven A. Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood 2010;116:2884–2896.
- Huynh E, Sigal D, Saven A. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results. Leuk Lymphoma 2009;50(Suppl. 1):12–17.
- Estey EH, Kurzrock R, Kantarjian HM, Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992;79:882–887.
- Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): relation to opportunistic infections. Blood 1992;79:888–894.
- Hoffman MA, Janson D, Rose E, Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. J Clin Oncol 1997;15:1138–1442.
- Tallman MS, Hakimian D, Rademaker AW, Relapse of hairy cell leukemia after 2-chlorodeoxyadnenosine: long-term follow-up of the Northwestern University experience. Blood 1996;88:1954–1959.
- Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 1994;84:4061–4063.